Ironwood Pharmaceuticals IRWD Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) in Prepaid Expense and Other Assets at other companies
Other financials
Where this comes from
Reported directly by Ironwood Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.
The official record: Ironwood Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ironwood Pharmaceuticals's increase (decrease) in prepaid expense and other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ironwood Pharmaceuticals's increase (decrease) in prepaid expense and other assets?
- Ironwood Pharmaceuticals (IRWD) reported increase (decrease) in prepaid expense and other assets of -$6M in Q1 2026.
- How has Ironwood Pharmaceuticals's increase (decrease) in prepaid expense and other assets changed year-over-year?
- Ironwood Pharmaceuticals's increase (decrease) in prepaid expense and other assets decreased by 1573.5% year-over-year, from $407K to -$6M.
- What is the long-term trend for Ironwood Pharmaceuticals's increase (decrease) in prepaid expense and other assets?
- Over 3 years (2021 to 2025), Ironwood Pharmaceuticals's increase (decrease) in prepaid expense and other assets has grown at a -15.2% compound annual growth rate (CAGR), from -$601K to -$367K.